In vitro release of metoprolol from various transdermal formulations
Banakar, U.V.
Die Pharmazie 45(2): 121-123
1990
ISSN/ISBN: 0031-7144 PMID: 2339167 Document Number: 349508
Document emailed within 1 workday
Related Documents
Kanikkannan, N.; Jayaswal, S.B.; Singh, J. 1994: Transdermal delivery of indomethacin: II. Effect of penetration enhancers on the in vitro percutaneous absorption from patch formulations Die Pharmazie 49(8): 619-620Pfeffer, M.; Sauerbrey, N.; Windt-Hanke, F.; Krause, W. 1990: In-vitro and in-vivo characterisation of two sustained release formulations for the antidepressant rolipram Arzneimittel-Forschung 40(11): 1191-1194
Witchitz, S.; Moisson, P.; Kolsky, H. 1984: A comparative trial of ordinary metoprolol tablets and metoprolol sustained-release tablets in hypertensive patients at rest and on exercise Pharmatherapeutica 3(8): 566-572
Jeck, T.; Edmonds, D.; Mengden, T.; Schubert, M.; Renz, I.; Weisser, B.; Vetter, W. 1992: Betablocking drugs in essential hypertension: transdermal bupranolol compared with oral metoprolol International Journal of Clinical Pharmacology Research 12(3): 139-148
Schmidt, P.C.; Kaupp, H. 1993: Stability and new formulations of hexetidine. 2. Formulations and in vitro bioavailability Die Pharmazie 48(11): 837-841
Gaál, J.; Szebeni, G.; Székács, G.; Fejér, E.; Wágner, O.; Szatmári, I.; Magyar, K.; Mezei, M. 2000: Transdermal formulations of deprenyl: guinea pig and pig models Neurobiology 8(2): 143-166
Seidegård, J.; Randvall, G.; Nyberg, L.; Borgå, O. 2009: Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulations Die Pharmazie 64(7): 461-465
Pandey, S.; Basheer, M.; Roy, S.; Udupa, N. 1999: Development and evaluation of transdermal formulations containing metronidazole and norfloxacin for the treatment of burn wound Indian Journal of Experimental Biology 37(5): 450-454
Stozek, T.; Krówczyński, L.; Bohdanowicz, T. 1983: Comparative studies on drug release from tablets in vitro and its biological availability. II. Biological availability of sodium salicylate from tablets of various formulations Acta Poloniae Pharmaceutica 40(1): 77-87
Shah, S.U.; Shah, K.U.; Rehman, A.; Khan, G.M. 2011: Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns Pakistan Journal of Pharmaceutical Sciences 24(2): 183-192
Umemura, M.; Ueda, H.; Tomono, K.; Nagai, T. 1990: Effect of diethyl-beta-cyclodextrin on the release of nitroglycerin from formulations Drug Design and Delivery 6(4): 297-310
Chasseaud, L.F.; Taylor, T.; Major, R.M.; Taylor, I.W.; Luckow, V.; Darragh, A.; Lambe, R.F. 1983: Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations Arzneimittel-Forschung 33(9): 1298-1301
Khaled, A.A.A.; Pervaiz, K.; Karim, S.; Farzana, K.; Murtaza, G. 2013: Development of in vitro-in vivo correlation for encapsulated metoprolol tartrate Acta Poloniae Pharmaceutica 70(4): 743-747
Ceci, V.; Mango, L.; Di Caprio, P.; Di Mario, F.; Milazzotto, F. 1985: The effects of transdermal controlled-release nitroderivatives. Evaluation of hemodynamic changes with a nuclear stethoscope La Clinica Terapeutica 114(4): 315-321
Gandini, R.; Assereto, R.; Castoldi, D.; Cunietti, E.; Garanzelli, P.; Monzani, W. 1987: Normal and slow-release formulations of bezafibrate: a comparative pharmacokinetic study in man International Journal of Clinical Pharmacology Research 7(2): 149-155
Gronda, D.; Cacciabue, L.; Mezzogori, C.; Rossin, M.; Ronchi, E. 1991: Absorption of short-acting insulin mixed with different slow-release formulations La Clinica Terapeutica 136(2): 95-100
Schall, R.; Luus, H.G. 1992: Comparison of absorption rates in bioequivalence studies of immediate release drug formulations International Journal of Clinical Pharmacology Therapy and Toxicology 30(5): 153-159
Wong, J.O.; Chiu, G.L.; Tsao, C.J.; Chang, C.L. 1997: Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain Acta Anaesthesiologica Sinica 35(1): 25-32
Ipsen, J. 1971: Mathematical relationship of in vitro release rates and biological availability of controlled-release nitroglycerin (nitrong) Current Therapeutic Research 13(3): 193-208
Civiale, C.; Ritschel, W.A.; Shiu, G.K.; Aiache, J.M.; Beyssac, E. 1991: In vivo-in vitro correlation of salbutamol release from a controlled release osmotic pump delivery system Methods and Findings in Experimental and Clinical Pharmacology 13(7): 491-498